Ainos, Inc.
Close on Oct 19, 2026
- Market cap
- $6.85M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 12, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 3, 2026 | After market close | $152 | $-0.62 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 13, 2026 | After market close | $161 | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 30, 2026 | After market close | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 13, 2025 | After market close | $2.17K | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | After market close | $4.66K | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | Before market open | $106.21K | $-0.21 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 7, 2025 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 5, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 13, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 8, 2024 | After market close | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 13, 2023 | After market close | – | – | – |
Press releases
Announcements Ainos filed with the SEC
GOVERNANCE POLICIES OF THE BOARD OF DIRECTORS
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics
Results of operations · EX-99.1 to Form 8-K
Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
Results of operations · EX-99.1 to Form 8-K
Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026
Results of operations · EX-99.1 to Form 8-K
Reports Third Quarter 2025 Financial Results
Results of operations · Shareholder vote results · EX-99.1 to Form 8-K
Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting
Other events · EX-99.1 to Form 8-K
Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026
Other events · EX-99.1 to Form 8-K
and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
Other events · EX-99.1 to Form 8-K
Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
Other events · EX-99.1 to Form 8-K
Reports Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
and ugo to Develop the World’s First Robot with a Sense of Smell
Other events · EX-99.1 to Form 8-K
Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ainos Reports Full Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the
Regulation FD disclosure · EX-99.1 to Form 8-K
Ainos Announces $1.75 Million Follow On Funding
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
Ainos , Inc. Announces Stock Consolidation
Other events · EX-99.1 to Form 8-K
Ainos Reports Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
The Parties entered into Non-Convertible Promissory Note dated January 1, 2020 for the Principal Amount of $84,000 with 1.85% per annum interest on unpaid principal and accrued interest, and a maturity date of January 1, 2021 (the “Note”).
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
Ainos Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Ainos Appoints Amanda Sung as New Chief Financial Officer
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Ainos Announces US$3 Million Convertible Notes Private Placement
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Ainos Reports Second Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
Material agreement · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Ainos Announces Closing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
Material agreement · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K